An arrow chart showing the estimated effects of Medicare's Drug Price Negotiation Program on out-of-pocket spending if it had been in effect in 2021, by race/ethnicity of enrollee. The DPNP might have dropped the median annual out-of-pocket cost by nearly 23%, from $1,250 to $967. It’s estimated all races/ethnicities would have seen a drop in costs, with Asian/Pacific Islanders seeing the largest drop, at -24.7%